Ascendis Pharma A/S ASND

ASND Quotes by TradingView
Institutional shares held 59.5 Million
80.3K calls
216K puts
Total value of holdings $9.83B
$13.3M calls
$35.6M puts
Market Cap $8.99B
55,810,200 Shares Out.
Institutional ownership 106.67%
# of Institutions 236

Quarterly Institutional Activity in ASND

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding ASND

View all
View all

Latest Institutional Activity in ASND

Top Purchases

Q1 2025
Toth Financial Advisory Corp Shares Held: 5.34K ($860K)
5.34K Shares purchased
New Holding
Q1 2025
Harbor Capital Advisors, Inc. Shares Held: 86K ($13.9M)
1.09K Shares purchased
1.28% Added
Q1 2025
Roxbury Financial LLC Shares Held: 10 ($1.61K)
10 Shares purchased
New Holding
Q1 2025
Org Partners LLC Shares Held: 6 ($967)
6 Shares purchased
New Holding
Q4 2024
T. Rowe Price Investment Management, Inc. Shares Held: 2.73M ($439M)
961K Shares purchased
54.42% Added
View All Buyers

Top Sells

Q1 2025
Gamma Investing LLC Shares Held: 587 ($94.6K)
90.9K Shares sold
99.36% Reduced
Q1 2025
Handelsbanken Fonder Ab Shares Held: 11.6K ($1.86M)
2.1K Shares sold
15.37% Reduced
Q1 2025
Rhumbline Advisers Shares Held: 1.39K ($223K)
74 Shares sold
5.07% Reduced
Q1 2025
Ronald Blue Trust, Inc. Shares Held: 368 ($59.3K)
39 Shares sold
9.58% Reduced
Q1 2025
Farther Finance Advisors, LLC Shares Held: 166 ($26.8K)
22 Shares sold
11.7% Reduced
View All Sellers

About ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

ASND Chart by TradingView
ASND Fundamental Data by TradingView

Insider Transactions at ASND

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on ASND

Follow Ascendis Pharma A/S and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ASND shares.

Notify only if
Any

Insider Trading

Get notified when an Ascendis Pharma A/S insider buys or sells ASND shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Ascendis Pharma A/S

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ASND